Form 4 for SLDB Solid Biosciences Inc.
Accepted 2024-12-04 00:00:00 ET · period of report 2024-12-02 · accession 0000950170-24-133340 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-12-04 | 2024-12-02 | SLDB | Howton David T | COO | M - OptEx | — | +13.1K | 20.7K | +170% | — |
| D | 2024-12-04 | 2024-12-03 | SLDB | Howton David T | COO | S - Sale+OE | $5.60 | -5,072 | 15.7K | -24% | -$28.4K |
| D | 2024-12-04 | 2024-12-02 | SLDB | Howton David T | COO | M - OptEx | $0.00 | -13.1K | 26.1K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-02 | M | A | 13,051 | — | 20,735 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs"). |
| 2 | Common | Common Stock | 2024-12-03 | S | D | 5,072 | $5.60 | 15,663 | D | — | — | (F2) This sale was made to cover withholding taxes following the vesting of the previously granted RSUs. The sale does not represent a discretionary trade made by Mr. Howton. |
| 3 | Derivative | Restricted Stock Units | 2024-12-02 | M | D | 13,051 | $0.00 | 26,103 | D | — · — to — | 13,051 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs"). (F3) The RSUs were granted on December 2, 2022 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary. |